合肥天曜完成数千万元A轮融资，厚雪资本领投

Core Insights - Hefei Tianyao New Materials Technology Co., Ltd. has recently completed a multi-million A round financing led by Huxue Capital, with participation from SMIC Juyuan and Guoyuan Fund, aimed at expanding production lines and product development, as well as exploring overseas markets and downstream detector integration business [1] Company Overview - Established in April 2020, Hefei Tianyao is located in Hefei Economic Development Zone and focuses on the research, production, and sales of third-generation strategic semiconductor crystal materials [1] - The company's core products include Cadmium Zinc Telluride (CdZnTe) substrates and devices, and it is expanding into high-end Indium Phosphide (InP) and Aluminum Nitride (AlN) compound semiconductor products [1] - Hefei Tianyao aims to break the technological monopoly held by Europe, the United States, and Japan, striving for self-controlled high-end semiconductor materials [1] Market Development - Photon CT using CdZnTe and Cadmium Telluride as detector materials has officially entered clinical use [1] - From the beginning of 2025 to the end of July, Siemens Medical has won bids from nearly 10 medical institutions, totaling 475 million yuan, with a single unit price of nearly 50 million yuan [1] - The photon counting spectral CT independently developed by United Imaging Healthcare has been installed in Zhongshan Hospital and Ruijin Hospital, initiating clinical testing and medical research [1] Strategic Positioning - The company recognizes the opportunity presented by the next generation of radiation detection technology and aims to become a core supplier in this wave [1] - Currently, Hefei Tianyao's CdZnTe products have achieved small batch supply in the medical field and have sent samples to several leading medical manufacturers, with expectations to enter a volume production phase next year [1]